144 related articles for article (PubMed ID: 27305828)
1. Design Considerations for Developing Hyperbranched Polyglycerol Nanoparticles as Systemic Drug Carriers.
Wong NK; Misri R; Shenoi RA; Chafeeva I; Kizhakkedathu JN; Khan MK
J Biomed Nanotechnol; 2016 May; 12(5):1089-100. PubMed ID: 27305828
[TBL] [Abstract][Full Text] [Related]
2. Investigation of hydrophobically derivatized hyperbranched polyglycerol with PEGylated shell as a nanocarrier for systemic delivery of chemotherapeutics.
Misri R; Wong NK; Shenoi RA; Lum CM; Chafeeva I; Toth K; Rustum Y; Kizhakkedathu JN; Khan MK
Nanomedicine; 2015 Oct; 11(7):1785-95. PubMed ID: 25981338
[TBL] [Abstract][Full Text] [Related]
3. Nontransformed and Cancer Cells Can Utilize Different Endocytic Pathways To Internalize Dendritic Nanoparticle Variants: Implications on Nanocarrier Design.
Wong NKY; Shenoi RA; Abbina S; Chafeeva I; Kizhakkedathu JN; Khan MK
Biomacromolecules; 2017 Aug; 18(8):2427-2438. PubMed ID: 28655275
[TBL] [Abstract][Full Text] [Related]
4. Influence of architecture of high molecular weight linear and branched polyglycerols on their biocompatibility and biodistribution.
Imran ul-haq M; Lai BF; Chapanian R; Kizhakkedathu JN
Biomaterials; 2012 Dec; 33(35):9135-47. PubMed ID: 23020861
[TBL] [Abstract][Full Text] [Related]
5. Tissue uptake of docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols and their effects on the morphology of the bladder urothelium.
Mugabe C; Raven PA; Fazli L; Baker JH; Jackson JK; Liggins RT; So AI; Gleave ME; Minchinton AI; Brooks DE; Burt HM
Biomaterials; 2012 Jan; 33(2):692-703. PubMed ID: 22014457
[TBL] [Abstract][Full Text] [Related]
6. Development and in vitro characterization of paclitaxel and docetaxel loaded into hydrophobically derivatized hyperbranched polyglycerols.
Mugabe C; Liggins RT; Guan D; Manisali I; Chafeeva I; Brooks DE; Heller M; Jackson JK; Burt HM
Int J Pharm; 2011 Feb; 404(1-2):238-49. PubMed ID: 21093563
[TBL] [Abstract][Full Text] [Related]
7. Construction of a High-Efficiency Drug and Gene Co-Delivery System for Cancer Therapy from a pH-Sensitive Supramolecular Inclusion between Oligoethylenimine- graft-β-cyclodextrin and Hyperbranched Polyglycerol Derivative.
Zhou X; Xu L; Xu J; Wu J; Kirk TB; Ma D; Xue W
ACS Appl Mater Interfaces; 2018 Oct; 10(42):35812-35829. PubMed ID: 30277375
[TBL] [Abstract][Full Text] [Related]
8. Biocompatible hyperbranched polyglycerol modified β-cyclodextrin derivatives for docetaxel delivery.
Xu Z; Zhang Y; Hu Q; Tang Q; Xu J; Wu J; Kirk TB; Ma D; Xue W
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():965-972. PubMed ID: 27987795
[TBL] [Abstract][Full Text] [Related]
9. Controlled quercetin release from high-capacity-loading hyperbranched polyglycerol-functionalized graphene oxide.
Islami M; Zarrabi A; Tada S; Kawamoto M; Isoshima T; Ito Y
Int J Nanomedicine; 2018; 13():6059-6071. PubMed ID: 30323593
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate-conjugated and hyperbranched polyglycerol-grafted Fe₃O₄ magnetic nanoparticles for targeted anticancer effects.
Li M; Neoh KG; Wang R; Zong BY; Tan JY; Kang ET
Eur J Pharm Sci; 2013 Jan; 48(1-2):111-20. PubMed ID: 23108167
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of carboxylic acid conjugated, hydrophobically derivatized, hyperbranched polyglycerols as nanoparticulate drug carriers for cisplatin.
Ye L; Letchford K; Heller M; Liggins R; Guan D; Kizhakkedathu JN; Brooks DE; Jackson JK; Burt HM
Biomacromolecules; 2011 Jan; 12(1):145-55. PubMed ID: 21128674
[TBL] [Abstract][Full Text] [Related]
12. In Vivo Biological Evaluation of High Molecular Weight Multifunctional Acid-Degradable Polymeric Drug Carriers with Structurally Different Ketals.
Shenoi RA; Abbina S; Kizhakkedathu JN
Biomacromolecules; 2016 Nov; 17(11):3683-3693. PubMed ID: 27750017
[TBL] [Abstract][Full Text] [Related]
13. Hydrotropic polymeric mixed micelles based on functional hyperbranched polyglycerol copolymers as hepatoma-targeting drug delivery system.
Zhang X; Zhang X; Yu P; Han Y; Li Y; Li C
J Pharm Sci; 2013 Jan; 102(1):145-53. PubMed ID: 23132353
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution and preliminary toxicity studies of nanoparticles made of Biotransesterified β-cyclodextrins and PEGylated phospholipids.
Perret P; Bacot S; Gèze A; Gentil Dit Maurin A; Debiossat M; Soubies A; Blanc-Marquis V; Choisnard L; Boutonnat J; Ghezzi C; Putaux JL; Lancelon-Pin C; Riou LM; Wouessidjewe D
Mater Sci Eng C Mater Biol Appl; 2018 Apr; 85():7-17. PubMed ID: 29407159
[TBL] [Abstract][Full Text] [Related]
16. Hyperbranched Polyglycerol Derivatives as Prospective Copper Nanotransporter Candidates.
Quadir M; Fehse S; Multhaup G; Haag R
Molecules; 2018 May; 23(6):. PubMed ID: 29861466
[TBL] [Abstract][Full Text] [Related]
17. Star-Shaped Amphiphilic Hyperbranched Polyglycerol Conjugated with Dendritic Poly(l-lysine) for the Codelivery of Docetaxel and MMP-9 siRNA in Cancer Therapy.
Zhou X; Zheng Q; Wang C; Xu J; Wu JP; Kirk TB; Ma D; Xue W
ACS Appl Mater Interfaces; 2016 May; 8(20):12609-19. PubMed ID: 27153187
[TBL] [Abstract][Full Text] [Related]
18. PEGylated hyperbranched polyphosphoester based nanocarriers for redox-responsive delivery of doxorubicin.
Chen C; Zheng P; Cao Z; Ma Y; Li J; Qian H; Tao W; Yang X
Biomater Sci; 2016 Mar; 4(3):412-7. PubMed ID: 26626655
[TBL] [Abstract][Full Text] [Related]
19. Impact of structural differences in hyperbranched polyglycerol–polyethylene glycol nanoparticles on dermal drug delivery and biocompatibility.
Kumar S; Alnasif N; Fleige E; Kurniasih I; Kral V; Haase A; Luch A; Weindl G; Haag R; Schäfer-Korting M; Hedtrich S
Eur J Pharm Biopharm; 2014 Nov; 88(3):625-34. PubMed ID: 25445303
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy.
Mugabe C; Hadaschik BA; Kainthan RK; Brooks DE; So AI; Gleave ME; Burt HM
BJU Int; 2009 Apr; 103(7):978-86. PubMed ID: 19007363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
